Safety and efficacy of simplified antibiotic regimens for outpatient treatment of serious infection in neonates and young infants 0-59 days of age in Bangladesh: design of a randomized controlled trial

Abdullah H Baqui, Samir Kumar Saha, A S M Nawshad Uddin Ahmed, Mohammad Shahidullah, Iftekhar Quasem, Daniel E Roth, Emma K Williams, Dipak Mitra, A K M Shamsuzzaman, Wazir Ahmed, Luke C Mullany, Simon Cousens, Stephen Wall, Neal Brandes, Robert E Black, Abdullah H Baqui, Samir Kumar Saha, A S M Nawshad Uddin Ahmed, Mohammad Shahidullah, Iftekhar Quasem, Daniel E Roth, Emma K Williams, Dipak Mitra, A K M Shamsuzzaman, Wazir Ahmed, Luke C Mullany, Simon Cousens, Stephen Wall, Neal Brandes, Robert E Black

Abstract

Background: Because access to care is limited in settings with high mortality, exclusive reliance on the current recommendation of 7-10 days of parenteral antibiotic treatment is a barrier to provision of adequate treatment of newborn infections.

Methods: We are conducting a trial to determine if simplified antibiotic regimens with fewer injections are as efficacious as the standard course of parenteral antibiotics for empiric treatment of young infants with clinical signs suggestive of severe infection in 4 urban hospitals and in a rural surveillance site in Bangladesh. The reference regimen of intramuscular procaine-benzyl penicillin and gentamicin given once daily for 7 days is being compared with (1) intramuscular gentamicin once daily and oral amoxicillin twice daily for 7 days and (2) intramuscular penicillin and gentamicin once daily for 2 days followed by oral amoxicillin twice daily for additional 5 days. All regimens are provided in the infant's home. The primary outcome is treatment failure (death or lack of clinical improvement) within 7 days of enrolment. The sample size is 750 evaluable infants enrolled per treatment group, and results will be reported at the end of 2013.

Discussion: The trial builds upon previous studies of community case management of clinical severe infections in young infants conducted by our research team in Bangladesh. The approach although effective was not widely accepted in part because of feasibility concerns about the large number of injections. The proposed research that includes fewer doses of parenteral antibiotics if shown efficacious will address this concern.

Trial registration: ClinicalTrials.gov NCT00844337.

Figures

FIGURE 1.
FIGURE 1.
Trial profile.

References

    1. Lawn JE, Cousens S, Zupan J Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: when? where? why? Lancet. 2005;365:891–900.
    1. Bryce J, Boschi-Pinto C, Shibuya K, et al. WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet. 2005;365:1147–1152.
    1. Ahmad OB, Lopez AD, Inoue M. The decline in child mortality: a reappraisal. Bull World Health Organ. 2000;78:1175–1191.
    1. Lawn JE, Kerber K, Enweronu-Laryea C, et al. Newborn survival in low resource settings–are we delivering? BJOG. 2009;116(suppl 1):49–59.
    1. National Institute of Population Research and Training (NIPORT), Mitra and Associates, Macro International Inc. Bangladesh Demographic and Health Survey. Dhaka, Bangladesh and Calverton, Maryland: National Institute of Population Research and Training, Mitra and Associates, and Macro International; 2007.
    1. Stoll BJ. The global impact of neonatal infection. Clin Perinatol. 1997;24:1–21.
    1. Bahl R, Martines J, Ali N, et al. Research priorities to reduce global mortality from newborn infections by 2015. Pediatr Infect Dis J. 2009;28(suppl 1):S43–S48.
    1. Bang AT, Bang RA, Baitule SB, et al. Effect of home-based neonatal care and management of sepsis on neonatal mortality: field trial in rural India. Lancet. 1999;354:1955–1961.
    1. Baqui A, Darmstadt GL, Williams E, et al. Rates, timing and causes of neonatal deaths in rural India: implications for neonatal health programs. Bull WHO. 2006;84:706–713.
    1. Darmstadt GL, Batra M, Zaidi AK. Oral antibiotics in the management of serious neonatal bacterial infections in developing country communities. Pediatr Infect Dis J. 2009;28(suppl 1):S31–S36.
    1. de_Zoysa I, Bhandari N, Akhtari N, et al. Careseeking for illness in young infants in an urban slum in India. Soc Sci Med. 1998;47:2101–2111.
    1. Willis JR, Kumar V, Mohanty S, et al. Gender differences in perception and care-seeking for illness of newborns in rural Uttar Pradesh, India. J Health Popul Nutr. 2009;27:62–71.
    1. Peterson S, Nsungwa-Sabiiti J, Were W, et al. Coping with paediatric referral–Ugandan parents’ experience. Lancet. 2004;363:1955–1956.
    1. Bazzano AN, Kirkwood BR, Tawiah-Agyemang C, et al. Beyond symptom recognition: care-seeking for ill newborns in rural Ghana. Trop Med Int Health. 2008;13:123–128.
    1. Winch PJ, Alam MA, Akther A, et al. Bangladesh PROJAHNMO Study Group. Local understandings of vulnerability and protection during the neonatal period in Sylhet District, Bangladesh: a qualitative study. Lancet. 2005;366:478–485.
    1. Jarvis WR. Controlling healthcare-associated infections: the role of infection control and antimicrobial use practices. Semin Pediatr Infect Dis. 2004;15:30–40.
    1. Pong A, Bradley JS. Clinical challenges of nosocomial infections caused by antibiotic-resistant pathogens in pediatrics. Semin Pediatr Infect Dis. 2004;15:21–29.
    1. Al-Eidan FA, McElnay JC, Scott MG, et al. Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children. J Antimicrob Chemother. 1999;44:709–715.
    1. Baqui AH, El-Arifeen S, Darmstadt GL, et al. Projahnmo Study Group. Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: a cluster-randomised controlled trial. Lancet. 2008;371:1936–1944.
    1. Khanal S, Sharma J, Gc VS, et al. Community health workers can identify and manage possible infections in neonates and young infants: MINI–a model from Nepal. J Health Popul Nutr. 2011;29:255–264.
    1. Baqui AM, Arifeen S, Williams E, et al. Effectiveness of home-based management of newborn infections by community health workers in rural Bangladesh. Pediatr Infect Dis J. 2009;28:304–310.
    1. Bang AT, Bang RA, Stoll BJ, et al. Is home-based diagnosis and treatment of neonatal sepsis feasible and effective? Seven years of intervention in the Gadchiroli field trial (1996 to 2003). J Perinatol. 2005;25(suppl 1):S62–S71.
    1. Sazawal S, Black RE Pneumonia Case Management Trials Group. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis. 2003;3:547–556.
    1. Hazir T, Fox LM, Nisar YB, et al. New Outpatient Short-Course Home Oral Therapy for Severe Pneumonia Study Group. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. Lancet. 2008;371:49–56.
    1. Young Infants Clinical Signs Study Group. Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet. 2008;371:135–142.
    1. Nestaas E, Bangstad HJ, Sandvik L, et al. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2005;90:F294–F300.
    1. Rao SC, Ahmed M, Hagan R. One dose per day compared to multiple doses per day of gentamicin for treatment of clinical or proven sepsis in neonates. Cochrane Database Syst Rev. 2006;(1):CD005091.
    1. Custer JW, Rau RE, editors. Children’s Medical and Surgical Center of the Johns Hopkins Hospital. The Harriet Lane Handbook: A Manual for Pediatric House Officers. 18th ed. Philadelphia: Mosby; 2009.
    1. Gras-Le Guen C, Boscher C, Godon N, et al. Therapeutic amoxicillin levels achieved with oral administration in term neonates. Eur J Clin Pharmacol. 2007;63:657–662.
    1. Blackwelder WC. “Proving the null hypothesis” in clinical trials. Control Clin Trials. 1982;3:345–353.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe